- Home
- EPSN vs CLNN Comparison
EPSN vs CLNN Comparison
Compare EPSN & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSN
- CLNN
- Stock Information
- Founded
- EPSN 2005
- CLNN 2012
- Country
- EPSN Canada
- CLNN United States
- Employees
- EPSN N/A
- CLNN N/A
- Industry
- EPSN Oil & Gas Production
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- EPSN Energy
- CLNN Health Care
- Exchange
- EPSN Nasdaq
- CLNN Nasdaq
- Market Cap
- EPSN 106.1M
- CLNN 120.6M
- IPO Year
- EPSN N/A
- CLNN N/A
- Fundamental
- Price
- EPSN $4.70
- CLNN $9.36
- Analyst Decision
- EPSN
- CLNN Strong Buy
- Analyst Count
- EPSN 0
- CLNN 6
- Target Price
- EPSN N/A
- CLNN $32.67
- AVG Volume (30 Days)
- EPSN 170.2K
- CLNN 134.4K
- Earning Date
- EPSN 11-05-2025
- CLNN 11-13-2025
- Dividend Yield
- EPSN 5.32%
- CLNN N/A
- EPS Growth
- EPSN 11.33
- CLNN N/A
- EPS
- EPSN 0.27
- CLNN N/A
- Revenue
- EPSN $45,709,605.00
- CLNN $214,000.00
- Revenue This Year
- EPSN $41.35
- CLNN N/A
- Revenue Next Year
- EPSN N/A
- CLNN $1,363.77
- P/E Ratio
- EPSN $17.43
- CLNN N/A
- Revenue Growth
- EPSN 46.76
- CLNN N/A
- 52 Week Low
- EPSN $4.36
- CLNN $2.28
- 52 Week High
- EPSN $8.50
- CLNN $13.50
- Technical
- Relative Strength Index (RSI)
- EPSN 43.61
- CLNN 52.56
- Support Level
- EPSN $4.67
- CLNN $8.29
- Resistance Level
- EPSN $4.89
- CLNN $8.86
- Average True Range (ATR)
- EPSN 0.21
- CLNN 1.14
- MACD
- EPSN 0.01
- CLNN -0.17
- Stochastic Oscillator
- EPSN 45.71
- CLNN 51.30
About EPSN Epsilon Energy Ltd. Common Share
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.